The Harvard Drug Group
FEI 1818658 · United States
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
0
Last FDA action
2017-08-02
9 years ago
FDA record
- 2017-08-02RecallRecall F-3515-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Calcionate Syrup, One Pint (473 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3516-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Cerovite Liquid, 8 oz. 236MLSource: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3517-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby D 3 Vitamin Liquid, 400 IUI/1 mL, 1 and 2/3 oz., 50 mLSource: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3518-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Fer-iron Liquid, 1 and 2/3 oz., 50 mLSource: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3519-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Liquid Vitamin C Supplement, 4 oz., 118 mLSource: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3520-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Ferrous Sulfate Liquid One Pint, (473 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3521-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Polyvitamin Liquid, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3522-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Polyvitamin Liquid with Iron, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3523-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Rugby Tri-vitamin Liquid, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3524-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major CertaVite Liquid, 8 oz. (236 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3525-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major D-Vita Drops, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3526-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major Ferrous Drops, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3527-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major Poly-Vita Drops, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3528-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major Poly-Vita Drops with Iron, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3529-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Major Tri-Vita Drops, 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3530-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Leader Liquid Multivitamin Supplement for Infants and Toddlers , 1 2/3 oz (50 mL)Source: FDA Enforcement Reports
- 2017-08-02RecallRecall F-3531-2017 · Class 2 · The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.Leader Liquid Vitamin D Supplement for Breastfed Infants, 1 T oz (50 mL)Source: FDA Enforcement Reports
- 2014-12-31RecallRecall F-0925-2015 · Class 3 · The firm received a complaint that the blister packets were missing labeling information on 12/16/2014, the firm investigated the labeling complaint and found that six 2 x 5 blister cards inside a carton was missing some or all of the product information on the back of the blister card.Thera Tablets with Beta Carotene Dietary SupplementSource: FDA Enforcement Reports